These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11808886)
21. Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants. Yaseen H; Khalaf M; Dana A; Yaseen N; Darwich M Am J Perinatol; 2008 Mar; 25(3):193-7. PubMed ID: 18425722 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. Singh BS; Sadiq HF; Noguchi A; Keenan WJ J Pediatr; 2002 Jul; 141(1):16-20. PubMed ID: 12091845 [TBL] [Abstract][Full Text] [Related]
23. Inhaler salbutamol for acute hyperkalemia in renal failure. Mocan MZ; Mocan G; Mocan H; Gorçin B Isr J Med Sci; 1993 Jan; 29(1):39-41. PubMed ID: 8454446 [No Abstract] [Full Text] [Related]
24. The administration of beta2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey. Habashy D; Lam LT; Browne GJ Eur J Emerg Med; 2003 Sep; 10(3):219-24. PubMed ID: 12972899 [TBL] [Abstract][Full Text] [Related]
25. Hypokalaemia following nebulized salbutamol in children with acute attack of bronchial asthma. Singhi SC; Jayashree K; Sarkar B J Paediatr Child Health; 1996 Dec; 32(6):495-7. PubMed ID: 9007778 [TBL] [Abstract][Full Text] [Related]
26. [Results of a National Survey in Germany on incidence and therapy of the nonoliguric hyperkalemia of the premature infant]. Mildenberger E; Versmold H Z Geburtshilfe Neonatol; 2002; 206(1):9-14. PubMed ID: 11887249 [TBL] [Abstract][Full Text] [Related]
33. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH Cochrane Database Syst Rev; 2012 Dec; 12(12):CD010179. PubMed ID: 23235685 [TBL] [Abstract][Full Text] [Related]
34. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Allon M; Shanklin N Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939 [TBL] [Abstract][Full Text] [Related]
35. Confounding by indication and channeling over time: the risks of beta 2-agonists. Blais L; Ernst P; Suissa S Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629 [TBL] [Abstract][Full Text] [Related]
37. Experimental hyperkalaemia in rabbits: effects of salbutamol and norepinephrine treatments on blood biochemistry and electrocardiography. Celik S; Bal R; Durgut R Acta Vet Hung; 2003; 51(3):331-42. PubMed ID: 14516161 [TBL] [Abstract][Full Text] [Related]
38. Salbutamol to facilitate management of acute hyperkalemia in liver transplantation: a case report. Kim DK; Chang SH; Yun IJ; Kwon WK; Woo NS Can J Anaesth; 2009 Feb; 56(2):142-6. PubMed ID: 19247762 [TBL] [Abstract][Full Text] [Related]
39. [The treatment of hyperkalemia with salbutamol]. Velásquez L; Muñoz R Bol Med Hosp Infant Mex; 1991 Nov; 48(11):775-9. PubMed ID: 1768353 [TBL] [Abstract][Full Text] [Related]
40. Effects of inhaled formoterol compared with salbutamol in ventilated preterm infants. Rieger-Fackeldey E; Reinhardt D; Schulze A Pulm Pharmacol Ther; 2004; 17(5):293-300. PubMed ID: 15477125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]